Balicatib

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBalicatib
Drug Alias Namebalicatibum巴利卡替AAE-581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin K inhibitors
TargetsCathepsin K
Therapy Area/IndicationsOsteoarthritis, KneeOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsOsteoarthritis, KneeOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A